ABOUT US  |  CONTACT US  |  RSS  |  ARCHIVE  |  2019-12-12  |  UPDATED: 1398/09/20 - 19:07:4 FA | AR | EN
Suu Kyi defends Myanmar at Rohingya genocide trial             Nicola Sturgeon set to reshape the politics of the British Isles             ĎNo election tomorrow,í Algerians chant ahead of presidential vote             Protests Held Against Indiaís Religion-Based Bill             Abdullah Says Result Announcement Will Not Be Acceptable             2 killed, 73 Wounded in Ongoing Taliban Attack near Bagram Base             US House Democrats unveil Trump impeachment charges             Endless unwinnable US war in Afghanistan             Saudi gunman ílegallyí purchased pistol used in US terror attack             EU Ďconcernedí about restrictions in Indian-controlled Kashmir             Jeremy Corbyn fends off tough interview by BBC             IEC May Announce Election Results Wednesday             Peace Talks Continue into Fourth Day             Confidential Documents on Afghanistan Released             US Democratic leading impeachment probe says Trump violated oath            

DATE PUBLISHED: 2017/10/5 - 12:48:45
VISIT: 2948
SHARE WITH YOUR FRIENDS

Europeís cancer drugs mostly ineffective: Study
 Europeís cancer drugs mostly ineffective: Study

European regulators approved 39 new cancer drugs between 2009 and 2013 despite having no evidence that they worked better than existing medicines, or at all, researchers said Thursday.

The number represented more than half of 68 treatments to become available for European cancer patients during this period, they said, "raising serious questions about the current standards of drug regulation."

Apart from dashing patient hopes, allowing unproven medicine onto the market also unnecessarily exposed people to toxicity inherent in all drugs, while inflating state pharmaceutical spending.

Writing in The BMJ medical journal, a team of public health experts expressed concern about the approval of often-pricey new cancer drugs by the EU regulator, the European Medicines Agency (EMA).

"This situation has negative implications for patients and public health," they warned.

"When expensive drugs that lack clinically meaningful benefits are approved and paid for within publicly funded healthcare systems, individual patients can be harmed, important societal resources wasted, and the delivery of equitable and affordable care undermined."

Many drugs were approved on the basis of inconclusive, early test results such as lab experiments, which were unable to predict whether they would actually make a patient feel better or live longer.

Another study, published in 2015, had found that most cancer drugs approved by the US Food and Drug Administration (FDA) between 2008 and 2012 similarly came with no evidence that they boosted patient survival or improved quality of life.

One of the authors of the American study, Vinay Prasad from the Oregon Health & Science University, pointed out that the average cancer drug in the US costs more than $100,000 (85,000 euros) per person per year.

"In the US, this broken system means huge expenditures on cancer drugs with certain toxicity but uncertain benefit," he wrote in a comment also carried by The BMJ.

"The US Medicare program is legally required to pay for any drug approved by the FDA without negotiation on price."

Given the toxicity and expense of cancer drugs, patients should be exposed only "when they can reasonably expect an improvement in survival or quality of life," said Prasad.

The new study found that 11 new drugs approved by the EMA between 2009 and 2013 were not shown to work any better than existing medicines to which they were compared, co-author Courtney Davis of Kingís College London told AFP.

In the case of 20 drugs, they worked no better than a placebo or "dummy" drug, and another eight were not compared to anything at all, "so we donít know whether they extend or improve life," she said.

 

LINK: http://ansarpress.com/english/9040






*
*

*



SEE ALSO

Tuberculosis Kills over 15,000 Afghans Every Year


Uganda confirms one death from Ebola-like Marburg virus


Ghani Criticizes Services of Afghan Hospitals, Calls for Reform


Fish oil could prevent diabetes in babies, study shows


At Ramadan, group pushes positive images of Muslims


One in four young women in UK reports mental health problems: Study


Afghan minister narrowly escapes HIV infection in syringe attack by drug addict


Russian scientists find new DNA repair method to cure Alzheimerís disease: Report


Quebec court rules Canadian Tobacco firms pay smokers


Abdul Rahim says he will continue to save lives with his new hands





VIEWED
MOST DISCUSSED







POLL

Modi, Merkel Discuss Afghanistan, Radicalisation And Terrorism

SEE RESULT


LAST NEWS

US judge blocks Trump from using $3.6 billion in Pentagon money on border wall

Suu Kyi defends Myanmar at Rohingya genocide trial

Nicola Sturgeon set to reshape the politics of the British Isles

ĎNo election tomorrow,í Algerians chant ahead of presidential vote

Protests Held Against Indiaís Religion-Based Bill

Abdullah Says Result Announcement Will Not Be Acceptable

2 killed, 73 Wounded in Ongoing Taliban Attack near Bagram Base

US House Democrats unveil Trump impeachment charges

Endless unwinnable US war in Afghanistan

Saudi gunman ílegallyí purchased pistol used in US terror attack

EU Ďconcernedí about restrictions in Indian-controlled Kashmir

Jeremy Corbyn fends off tough interview by BBC

IEC May Announce Election Results Wednesday

Peace Talks Continue into Fourth Day

Confidential Documents on Afghanistan Released

US Democratic leading impeachment probe says Trump violated oath

Fox Ďpandersí to Democrats, Trump complains, calling it ípatheticí

US, Taliban Not Agreed on Reduction of Violence: Sources

Ghani Calls for Regional, Intíl Support for Afghan Peace

Abdullahís Team Sees No Outcome from Election Meeting

Pentagon chief says plans to shift US military focus to Russia, China

Body of Japanese Aid Worker Arrives in Japan

US-Taliban Talks Continue for Second Day

Turkey to Host Meeting on Afghanistan

Meeting on Afghan Election Did Not Break Impasse

Khalilzad Will ďRejoin Talks with the TalibanĒ: US

Abdullahís Supporters Continue Protests in the North

Head of Japanese NGO in Nangarhar Has Died From Gunfire Wounds

US Troop Drawdowns In Afghanistan ĎNot Tiedí to Taliban Deal: Esper

Abdullahís Supporters Stage Protests in the North

Childrenís Advocates Call for ĎPromptí Probe into Logar Case

Germans Ready to Extend Their NATO Mission: Minister

Trump blasts impeachment inquiry as Ďa hoaxí

Italy PM defends reform of euro zone bailout fund but seeks concessions

Khalid, Miller Meets VP Dostum in Jawjzan

Freed Taliban Hostage Australian Professor Says He Never Gave Up Hope

Politicians Working on Plan to ĎEnd Crisisí

Ghani Orders Termination of Gold, Copper Mining Contracts

Knowledge Summit 2019: MBRF Unveils Findings of ĎFuture of Knowledge

Australian Professor on Three-Year Ordeal Taliban Hostage


MEDICAL NEWS








ANSAR PRESS ©  |  ABOUT US  |  CONTACT US  |  MOBILE VERSION  |  LINKS  |  DESIGN: Negah Network Co.
All right reserved. Use this website by mentioning the source (link) is allowed. ›—ś‘ź«Ś «یš —š ی šŕŠ»šŌ«š